As an approach to targeted repression of genes of interest, we describe the development of human estrogen receptor (ER) ␣-KRAB repressor domain chimeras that are potent ligand-dependent repressors of the transcription of estrogen response element (ERE)-containing promoters and analyze their mechanisms of action. Repression by the KRAB domain was dominant over transactivation mediated by ER AF1 and AF2. An ERE and an ER ligand (estrogen or antiestrogen) were required for repression. Studies with several promoters and cell lines demonstrated that the presence of EREs, rather than the capacity for estrogen induction, determines the potential for repression of a gene by the KRAB-ER␣-KRAB (KERK) chimera. A single consensus ERE was sufficient for repression, but the KERK chimera was unable to suppress transcription from the imperfect ERE in the native pS2 promoter. We recently reported mutations that enhance binding of a steroid receptor DNA-binding domain to the ERE. Introducing these mutations into wild-type ER enhanced transactivation from the pS2 ERE. Insertion of these mutations into KERK created the novel repressor KERK-3M, which is a potent repressor of both ER-induced and basal transcription on a promoter containing the pS2 ERE. These modified ER-KRAB chimeras should prove useful as new tools for the functional analysis and repression of ERregulated genes.
transcription regulators that are capable of high affinity binding to a specific DNA sequence, termed the estrogen response element (ERE). On binding to the ER, estrogens exert a wide variety of biological effects, including effects on the development and function of male and female reproductive tissues, bone remodeling, and the cardiovascular system, and have been implicated in breast and uterine cancer. Estrogen-regulated genes therefore represent important therapeutic targets. If expression of estrogen-regulated genes could be effectively suppressed, both the discovery and the elucidation of their roles in various physiological processes would be greatly facilitated. Selective estrogen receptor modulators (SERMs) (reviewed in Ref. 1) and ER mutants displaying a dominantnegative phenotype (2) have been used to suppress ER-induced transcription. However, SERMs can display significant agonist activity in specific tissue or cell backgrounds (3, 4) . Recently, a number of hER␣ mutants displaying a dominant-negative phenotype have been described (2, 5) . Although these hER␣ mutants and SERMs disrupt estrogen-induced transcription, they do not affect basal transcription of estrogen-regulated genes. We therefore designed novel hER␣ variants for ligand-dependent repression of the transcription of ERE-containing genes.
To create ligand-dependent repressors targeted to ERE-containing genes, we constructed chimeras of ER␣ and the KRAB (Krü ppel-associated box) transcription repression domain (6 -9) of the KOX1 protein (also named ZNF10) (7, 8) . The KRAB domain is a highly conserved 75-amino acid region found in approximately one-third of the vertebrate Krü ppel-like (Cys 2 -His 2 ) zinc finger proteins (6) . When tethered to DNA, the KRAB domain suppresses transcription activation mediated by a variety of transcription factors (7, 9 -12) , represses transcription mediated by all three classes of eukaryotic RNA polymerase (10 -12) , and functions as a repressor even when bound at DNA sites up to 3 kilobases from the transcription initiation site (10, 11, 13, 14) .
In this study, we characterize and examine mechanistically the ability of ER-KRAB domain chimeras to suppress transcription of synthetic genes containing the consensus ERE or the imperfect ERE from the natural pS2 promoter (15) . Although the ER-KRAB chimeras were found to exhibit efficient estrogen-or antiestrogen-dependent repression of promoters containing the consensus ERE in several cell and promoter contexts, they were unable to repress transcription from the imperfect ERE found in the pS2 promoter. To achieve repression from a promoter containing the native pS2 ERE, we developed a novel repressor with increased affinity for this imperfect ERE. We recently described the use of a modified p22 challenge phage system to select mutant steroid receptor DNAbinding domains with altered DNA binding specificity and an enhanced affinity for EREs (16) . By integrating information obtained from those genetically selected mutant DNA-binding modules with the ligand-regulated ER-KRAB chimeras, we produced a prototype of a new class of targeted gene repressor. This novel ER-KRAB chimera (KERK-3M) is a potent repressor of both basal and estrogen-induced activities of genes containing the consensus ERE or the imperfect pS2 ERE.
EXPERIMENTAL PROCEDURES
Cloning of hER␣-KRAB Chimeras-To fuse the Kox1 KRAB domain to hER␣, unique NheI sites were introduced into the hER␣ cDNA sequence. To facilitate sequence verification after mutagenesis, the following hER fragments from plasmid pCMV5hER were initially subcloned into pGEM11Zf(ϩ) (Promega, Madison, WI): 1) the EcoRI/NotI N-terminal fragment, 2) the NotI/HindIII fragment containing the LBD, and 3) the HindIII/BamHI C-terminal fragment of pCMV5hER and pCMV5hERL540Q (3, 17) . QuikChange mutagenesis (Stratagene) was then employed to introduce unique NheI sites into these plasmids, generating the vectors pG11EnsNhe, pG11EnhNhe, pG11EbhNhe, and pG11QbhNhe, respectively. To achieve this, the following primers were used: for pG11EnsNhe, GCCCGCGGCCACGGACCGCTAGCAATGAC-CATGACCCTCCA (forward) and TGGAGGGTCATGGTCATTGCTAG-CGGTCCGTGGCCGCGGGC (reverse); for pG11EnhNhe, AAGTATGG-CTATGGAGCTAGCCAAGGAGACTCGCTA (forward) and TAGCGAG-TCTCCTTGGCTAGCTCCATAGCCATACTT (reverse); and for pG11EbhNhe and pG11QbhNhe, GAGGCAGAGGGTTTCCTGCTAGC-TGCCACAGTCTGAG (forward) and CTCAGACTGTGGCAGCTAGCA-GGAAACCCTCTGCCTC (reverse).
The KOX1 cDNA (9) was a kind gift of Dr. Hans-Jü rgen Thiesen (University of Rostock, Rostock, Germany). Polymerase chain reaction amplification by Taq DNA polymerase (Life Technology, Inc.) generated fragments of the KOX1 (ZNF10) protein (amino acids 1-91) containing both the KRAB A-and B-domains that could be cloned either at the N terminus of hER and ⌬A/B-hER (N-KRAB) or at the C terminus of hER and hER L540Q (C-KRAB). The following oligonucleotides were used: N-KRAB, CAGAATTCATGGATGCTAAGTCACTAAC (forward) and TATCTAGAAATGCAGTCTCTGAATCAG (reverse); and C-KRAB, CT-TCTAGATATGGATGCTAAGTCACTAAC (forward) and ATGGATC-CTAAATGCAGTCTCTGAATCAG (reverse).
The resulting amplified products were subcloned into the pGEM-T vector (Promega). After verifying the sequence, the N-KRAB insert was obtained as an EcoRI/XbaI fragment and together with the NheI/NotI fragment of plasmid pG11EnsNhe was cloned into pCMV5hER, pCMV5hERL540Q, and pCMV5hERFS digested with EcoRI/NotI or with the NheI/HindIII fragment of pG11EnhNhe into pCMV5hER, pCMV5hERL540Q, and pCMV5hERfs digested with EcoRI/HindIII. These manipulations yielded plasmids pCMV5KER, pCMV5KERQ, pCMV5KERFS, pCMV5K-⌬A/B-ER, pCMV5K-⌬A/B-ERQ, and pCMV5K-⌬A/B-ERFS, respectively. The C-KRAB insert was obtained as an XbaI/BamHI fragment and ligated into NheI/BamHI-digested plasmids pG11EbhNhe and pG11QbhNhe, respectively. The resulting hER LBD-KRAB fusions were then obtained as XbaI/BamHI fragments and cloned into similarly digested plasmids pCMV5hER, pCMV5-⌬A/ B-hER, pCMV5KER, and pCMV5K-⌬A/B-ER. These manipulations yielded plasmids pCMV5ERK, pCMV5ERQK, pCMV5-⌬A/B-ERK, pCMV5-⌬A/B-ERQK, pCMV5KERK, pCMV5KERQK, pCMV5K-⌬A/B-ERK, and pCMV5K-⌬A/B-ERQK, respectively.
To establish that ERE binding is required for transcription repression by the ER-KRAB chimera, its wild-type hER DNA-binding domain was replaced through exchange of the respective NotI/HindIII fragments with a mutated DNA-binding domain. This latter DBD no longer recognizes the ERE sequence due to the E203G, G204S, and A207V mutations in the DNA recognition helix (5, 17) . To establish that a functional KRAB domain is required for transcription repression, the previously reported E26A, E27A, and E28A mutations (7) were introduced into the KRAB domain of the ER-KRAB chimera with the QuikChange protocol using the following oligonucleotides: GACTTCACCAG-GGCGGCCGCGAAGCTGCTGGAC (forward) and GTCCAGCAGCTTC-GCGGCCGCCCTGGTGAAGTC (reverse).
A FLAG-GAL4-KRAB chimera was constructed to serve as a control. Dr. C. M. Chiang (University of Illinois) provided us with a FLAG-GAL4-VP16 fusion construct in the bacterial expression plasmid pET11d (Novagen). We obtained the FLAG-GAL4-VP16 coding sequence by digestion with NcoI and subsequent fill in with Pfu polymerase followed by BamHI digestion to liberate the insert. The gelpurified fragment was then ligated into the mammalian expression vector pcDNA3 (Stratagene) to generate plasmid pFGVP16. For this purpose, pcDNA3 was initially digested with HindIII, filled in with Pfu polymerase, and subsequently digested with BamHI. The GAL4 C terminus was obtained in conjunction with a polylinker as a polymerase chain reaction fragment from plasmid pM (CLONTECH), changing the Dam methylation-sensitive BclI site into an ApaI site in the process. The polymerase chain reaction fragment was digested with XhoI/ApaI and ligated into similarly digested plasmid pFGVP16 to generate plasmid pFGmcs. In our transfections, this plasmid is referred to as GAL4. The above described N-terminal KRAB domain, obtained as an EcoRI/ BamHI fragment, was ligated into plasmid pFGmcs, which provided the stop codon, generating the vector pFGK.
Plasmid (ERE) 4 -pGL3-SV40PE that we constructed served as an indicator of repression. This plasmid is derived from plasmid pGL3-Control (Promega) and contains four consensus EREs upstream of the SV40 promoter, which renders the plasmid estrogen-responsive. The SV40 promoter and enhancer in this plasmid constitutively drive the expression of firefly luciferase; therefore, both activation and repression can be studied effectively. The estrogen response elements were obtained from plasmid (ERE) 4 -TATA-CAT (18) , which was digested with HindIII, blunt-ended with Pfu polymerase, and religated to generate an NheI site. An NheI/BglII digest was then performed to liberate the EREs. This fragment was ligated into similarly digested vector pGL3-Control. Another series of pGL3-Control-based reporters was constructed containing one, two, and four EREs, respectively. To achieve this, an extraneous BglII site was removed from the multiple cloning site of plasmids pGL3-(ERE) 1 -TATA, pGL3-(ERE) 2 -TATA, and pGL3-(ERE) 4 4 -PGL3-EF1␣ were constructed. Plasmid pGL3-TK was constructed by inserting the thymidine kinase promoter/enhancer as a BglII/HindIII fragment obtained from plasmid pRL-TK (Promega) into similarly digested plasmid pGL3-Basic (Promega). Plasmid pGL3-EF-1␣ was constructed by inserting the elongation factor 1␣ promoter/ enhancer obtained as a HindIII/NcoI fragment from plasmid pEFmyc/ nuc (Invitrogen) into similarly digested plasmid pGL3-Basic. These plasmids were then made estrogen-responsive by incorporating four copies of the ERE obtained as an NheI/BglII fragment from plasmid pGL3-(ERE) 4 -TATA. To test the ability of ER-KRAB chimeras to repress transcription from a single non-consensus ERE, a 345-base pair SacI/SmaI fragment containing the pS2 ERE was isolated from the pS2 promoter and inserted into similarly digested plasmid pGL3-Promoter, resulting in plasmid pGL3-pS2-SV40P. Plasmid pGL3-(pS2 ERE) 1 -TATA is derived from the pGL3-(ERE) 1 -TATA reporter by mutation of 2 base pairs in the consensus ERE. The imperfect ERE created, 5Ј-AGGTCActgTGGCCC-3Ј, is the ERE in the pS2 5Ј-flanking region. For studies with the FLAG-GAL4-KRAB fusions, the repression reporter plasmid G 5 -pGL3-Control was constructed by inserting five GAL4-binding sites obtained as an XhoI/BamHI fragment from plasmid pG5E1b (19) into XhoI/BglII-digested plasmid pGL3-Control.
Cell Maintenance, Transfection, and Reporter Gene Assays-HepG2 human hepatoma cells and HeLa cells were maintained in a humidified 5% CO 2 -containing environment at 37°C in Dulbecco's minimal essential medium (Sigma) supplemented with 10% charcoal/dextran-stripped fetal bovine serum (Atlanta Biologicals, Inc., Atlanta, GA) 50,000 units/ liter penicillin, and 50 mg/liter streptomycin (Life Technologies, Inc.). Chinese hamster ovary (CHO) cells were maintained in Dulbecco's modified Eagle's medium/nutrient mixture F-12 (1:1; Sigma), 29.2 mg/ liter L-glutamine (Sigma), 5% charcoal/dextran-stripped newborn bovine serum (Atlanta Biologicals, Inc.), 50,000 IU/liter penicillin, and 50 mg/liter streptomycin. MCF-7 cells were maintained in Eagle's minimal essential medium plus phenol red supplemented with 5% newborn calf serum, 50,000 IU/liter penicillin, and 50 mg/liter streptomycin. At least 2 days prior to the experiment, cells were transferred to 1:1 Dulbecco's modified Eagle's medium/nutrient mixture F-12, 29.2 mg/liter L-glutamine, 5% charcoal/dextran-stripped newborn bovine serum, 50,000 IU/ liter penicillin, and 50 mg/liter streptomycin.
Transient transfections were carried out by the calcium phosphate coprecipitation method. Briefly, cells were plated in 60-mm dishes at a density of 4.5 ϫ 10 5 cells/dish for HepG2 cells and 2.5 ϫ 10 5 cells/dish for CHO cells, in 6-well plates at 1.0 ϫ 10 5 cells/well, or in 12-well plates at 5 ϫ 10 4 cells/well. The next day, the medium was replaced; and 2-6 h later, calcium phosphate crystals were added. 12-16 h later, the cells were subjected to a 3-min shock with 20% glycerol in Tris-buffered saline, pH 7.4. The medium was replaced; and where appropriate, hormone was added to the indicated concentrations. The cells were harvested 48 h later for the reporter gene assay by addition of appro-priate amounts of passive lysis buffer (Promega). The activity of the resulting extracts was determined using the dual luciferase assay protocol (Promega) according to the manufacturer's directions on a Monolight 2010 luminometer.
RESULTS

hER-KRAB-mediated Repression Requires Ligand, EREs
, and a Functional KRAB Domain-To produce the KRABhER␣-KRAB (KERK) construct (see Fig. 2B ), the complete KRAB repressor domain (containing both the KRAB A-and B-domains) was placed at both the N and C termini of hER␣. The ability of KERK to repress transcription of a reporter gene containing the SV40 promoter and enhancer (SV40PE) and four consensus EREs was tested. This (ERE) 4 -pGL3-SV40PE reporter plasmid exhibits substantial intrinsic activity, referred to as basal transcription, which is further enhanced by ligand-activated ER. To establish the effect of ligand on the ability of a KRAB construct to repress transcription, transient transfections were carried out in ER-negative HepG2 human hepatoma cells in the presence or absence of the estrogen moxestrol, which liver cells metabolize more slowly than 17␤-estradiol (20) . The basal promoter activity of the (ERE) 4 -pGL3-SV40PE reporter plasmid in the absence of estrogen receptor was set at 100%. Cotransfected hER␣ expression plasmid elicited a moxestrol-dependent 3-4-fold induction of luciferase activity (Fig. 1A) , whereas increasing amounts of unliganded ER did not affect transcription. In the absence of an ER ligand and at 20 ng of transfected KERK expression plasmid, there was a modest 1.6-fold repression of transcription. However, full repression (4.8-fold) required the presence of ligand (Fig. 1A) . Since KRAB repression was largely ligand-dependent, subsequent studies were carried out in the presence of ligand.
The sequence specificity of repression was shown by the inability of an hER␣-KRAB (ERK) chimera (shown in Fig. 2 , A and B) to repress transcription from the five GAL4-binding sites in the G 5 -pGL3-SV40PE reporter (Fig. 1B) and by the inability of GAL4-KRAB to repress transcription from the four EREs in the (ERE) 4 -pGL3-SV40PE reporter (Fig. 1C) . The reporters were functional since GAL4-KRAB repressed transcription by Ͼ90% from the G 5 -pGL3-SV40PE reporter (Fig.  1B) , whereas hER activated basal transcription by 3.8-fold and ERK repressed transcription by 4.5-fold on the (ERE) 4 -pGL3-SV40PE reporter (Fig. 1C) . The issue of DNA binding specificity was also addressed by introducing mutations into the DNA recognition helix of the hER DBD that shift the specificity from the ERE to the glucocorticoid response element and thereby prevent binding to the ERE (5, 17) . This chimera (ERKmut-DBD) no longer repressed transcription on either of the reporter plasmids (Fig. 1, B and C) . As expected, introducing the mutations E26A, E27A, and E28A into the KRAB domain (7) of ERK (ERKmutKRAB) abolished repression (Fig. 1C) .
Influence of Ligand and Estrogen Receptor AF1 and AF2 Mutations on KRAB Repression-Although the mechanism of transcription repression by the KRAB domain is not fully understood, KRAB has been shown to interact with the human corepressors TIF1␣ and TIF1␤ (also isolated as KAP-1) and their murine homologue KRIP-1 (13, 21, 22) . Interestingly, TIF1␣ (23), but not TIF1␤, is thought to act as a coactivator of steroid receptor-mediated transcription activation by interacting with the AF2 region of ligand-occupied steroid receptors. The interactions of TIF1␣ with the KRAB domain and with the AF2 region of steroid receptors take place via two distinct interaction domains found within the TIF1␣ protein and might interfere with the ability of the KRAB domain to function as a repressor in the presence of AF2. It was therefore of interest to examine whether presenting the KRAB domain in different ways in the context of estrogen receptor chimeras would favor a functional interaction of KRAB and its corepressors, thereby enabling the KRAB domain to operate more effectively as a transcription repressor.
FIG. 1.
Repression by ERK is DNA sequence-specific and requires ligand and a functional KRAB domain. A, transcription repression properties of the KERK chimera and activation properties of hER␣ on the (ERE) 4 -pGL3-SV40PE reporter plasmid in HepG2 cells in the absence and presence of 10 nM moxestrol (Mox). All experiments were carried out in the presence of 10 nM moxestrol, except where noted. Luciferase activity from the transfected reporter was determined as described under "Experimental Procedures." The activity of the reporter plasmid alone was normalized to 100 kilo-luciferase units. To establish whether both sequence-specific DNA binding and a functional KRAB domain are required for repression by the ERK chimera, the effects on transcription from the (G) 5 -pGL3-SV40PE and (ERE) 4 -pGL3-SV40PE reporter plasmids in HepG2 cells were examined by cotransfection of the indicated GAL4 DBD-and hER-based effector constructs (B and C, respectively). The data obtained were normalized against the luciferase activity of the indicated reporter plasmid alone. The data in A-C represent the mean Ϯ S.E. of at least three independent transfections. Enh, enhancer.
To analyze the effect of position and the influence of the ER activation domains on KRAB repression, the KRAB domain was fused in frame at either the N or C terminus and at both ends of hER␣ (Fig. 2, A and B) . To prevent interaction with steroid receptor coactivators, we also employed a number of hER␣ mutants in which AF1 and/or AF2 activity was ablated. Since the ligand-independent activation function AF1 is spread through much of the A/B-domain of hER␣ (24, 25) , AF1 ablation was achieved by deleting the entire A/B-domain (amino acids 1-178, indicated as ⌬A/B). Removal of the ligand-dependent activation function AF2 was achieved through introduction of either of two point mutations in the ligand-binding domain, L540Q and S554fs (Q and FS, respectively) ( Fig. 2A) . These mutations confer a dominant-negative phenotype on hER␣ (2), which might further potentiate transcription repression by the KRAB domain.
The ability of the ER-KRAB chimeras to repress transcription was determined by cotransfecting the (ERE) 4 -pGL3-SV40PE reporter plasmid and increasing amounts (5, 20, or 40 ng) of the expression plasmid encoding each KRAB chimera into HepG2 cells in the presence of 10 nM moxestrol (Fig. 2B) . Even at the lowest amount transfected, all of the chimeras achieved at least 45% repression, and most achieved Ͼ55% repression. The differences in repression among the various constructs were modest. All of the ER-KRAB chimeras are therefore effective transcription repressors. Surprisingly, ablation of AF1 and/or AF2 activity had little or no effect on the extent of KRAB repression. For example, at 40 ng of transfected expression plasmid, the AF2-containing chimera KER repressed transcription by 75%. Ablation of AF2 by the L540Q mutation in the KERQ chimera or by the S554fs mutation in the KERFS chimera (2) had little effect on the magnitude of transcription repression. Deletion of AF1 modestly enhanced repression only when the KRAB domain was present at the C terminus of the protein. At 40 ng of transfected expression plasmid, the ERK and ⌬A/B-ERK constructs repressed transcription by 78 and 88%, respectively. The KERK, KERQK and ⌬A/B-ERK constructs were the most effective, with each repressing transcription by 87-88%. Since these differences were negligible, we elected to use the KERK repressor in subsequent experiments.
KRAB-mediated Repression Is Not Blocked by Trichostatin A-It has been proposed that KRAB repression is mediated through recruitment of the corepressors TIF1␣ and TIF1␤. These proteins contain RBCC (RING finger-B boxes-coiled coil), PHD finger, and bromodomain interaction domains. Since these domains are also found in complexes implicated in chromatin-mediated transcription repression, it has been suggested that KRAB may act by modifying chromatin to achieve a repressive state (21, 26) . Many chromatin modifiers recruit histone deacetylases or contain intrinsic histone deacetylase activity. The histone deacetylase inhibitor trichostatin A has been widely used to identify chromatin events based on histone deacetylation (27, 28) . Addition of 0.25 or 1 M trichostatin A had no effect on the ability of the KERK or GAL4-KRAB chimeras to repress transcription from several reporter genes (Fig. 3) . Although trichostatin A failed to affect KRAB repression, it is functional in HepG2 cells, as judged by its ability to strongly potentiate moxestrol/ER-mediated transcription of a stably integrated vitellogenin promoter in HepG2 cells. 2 Effect of Cell Line, Promoter, and Ligand on ER-KRAB Repression-We wanted to determine whether KRAB repression was equally effective in different cell lines on strong and weak promoters and whether the KRAB chimera could repress transcription in the presence of wild-type ER␣ or ER␤ (29, 30) . To examine the effect of promoter strength on KRAB repression, repression was evaluated in reporter genes containing the rel-2 C. Mao and D. J. Shapiro, submitted for publication.
FIG. 2.
Influence of AF1 and AF2 on repression properties of hER-KRAB chimeras. A, the KRAB domain was fused in frame at either the N or C terminus and at both termini of full-length wild-type hER␣, at the N terminus of several hER␣ mutants in which the ligandindependent activation function (AF1) was removed through deletion of the A/B-domain (⌬A/B) or in which the ligand-dependent activation function (AF2) was ablated by point mutations L540Q (Q) and S554fs (FS), or a combination of these two classes of mutations. In the constructs, the DBD is indicated as a shaded box, and the AF2 mutations in the LBD are indicated as Q (L540Q) and FS (S554fs), respectively. Ablation of AF1 activity, achieved through deletion of the first 178 amino acids of hER␣, is indicated as ⌬A/B. The KRAB repressor domain is indicated as a black box. B, increasing amounts (5, 20, or 40 ng) of the expression plasmids encoding the hER-KRAB chimeras were transfected into HepG2 cells using the (ERE) 4 -pGL3-SV40PE plasmid as a reporter. A vertical line in the ER LBD indicates the L540Q point mutation (Q), whereas the striped box extending the LBD C terminus represents the additional amino acid sequence introduced by the S554fs frameshift mutation (FS). The data obtained were normalized against the luciferase activity of the reporter plasmid alone, which was set at 100%. The data in B represent the mean Ϯ S.E. of at least three independent transfections. atively weak thymidine kinase promoter, the strong SV40 promoter/enhancer (SV40PE), and the extremely powerful elongation factor 1␣ promoter. Repression in the presence of endogenous ER was determined by cotransfecting plasmids encoding wild-type ER␣ or ER␤ into the cells along with the KERK expression plasmid. Even though we used three times more hER␤ expression plasmid than hER␣ expression plasmid, in agreement with earlier studies (29, 31) , hER␤ was significantly less effective in activating transcription than hER␣ (Fig.  4, A and D; 3.3-fold versus 15-fold in Fig. 4A ; note that the ordinate of A is set on a logarithmic scale).
There was an inverse correlation between promoter strength and the additional contribution to promoter activity due to hER␣-activated transcription. hER␣ increased transcription 15-, 2.6-, and 0.9-fold on the (ERE) 4 -pGL3-TK, (ERE) 4 -pGL3-SV40, and (ERE) 4 -pGL3-EF-1␣ reporter plasmids, respectively. However, on all promoters, in both HepG2 cells (Fig. 4 , A-C) and CHO cells (Fig. 4, D-F) , increasing amounts of transfected KERK repressed all, or nearly all, of the hER␣-or hER␤-induced activity and most of the basal promoter activity. In the absence of hER, KERK repressed up to 82-92% of basal promoter activity on these reporter plasmids. When transfected at a 3-fold excess relative to hER␣, KERK repressed thymidine kinase promoter activity to 45% of the basal thymidine kinase promoter activity, which is a 33-fold reduction from the hER␣-induced level of transcription (Fig. 4A) .
In CHO cells, we tested the thymidine kinase, SV40, and Xenopus vitellogenin B1 promoters using the (ERE) 4 -pGL3-TK, (ERE) 4 -pGL3-SV40PE, and pGL3-EREVIT reporter plasmids, respectively. These experiments suggested an interesting difference between transcription activation and repression. The EREVIT promoter contained only one consensus ERE, two functional imperfect EREs, and one nonfunctional imperfect ERE (32) . The other test promoters contained four consensus EREs. In CHO cells, hER␣ activated transcription more powerfully from the EREVIT promoter than from the other test promoters (3.4-fold versus 1.7-1.9-fold). However, transcription repression by the KRAB chimera was more closely correlated with the number of consensus EREs, and repression was somewhat more effective with the (ERE) 4 -pGL3-TK and (ERE) 4 pGL3-SV40PE reporters than with the pGL3-EREVIT reporter. At a 1:1 ratio of transfected KERK and hER␣, repression was clearly dominant, as activity was reduced 3.3-3.6-fold relative to the activity in the presence of hER␣ alone (Fig. 4, D-F) . Similar results were obtained when repression by KERK from the (ERE) 4 -pGL3-TK and (ERE) 4 -pGL3-SV40PE reporter genes was evaluated in the ER-negative breast cancer cell line MDA-MB231 and in HeLa cells (data not shown).
To evaluate the ability of a KRAB chimera to repress transcription in cells containing high levels of endogenous ER, we tested the effectiveness of the KERK chimera in ER-positive MCF-7 human breast cancer cells (Fig. 5) . The ability of SERMs to act as KERK ligands to potentiate KRAB repression was also tested. SERMs, which are mixed agonists/antagonists such as 4-hydroxytamoxifen (OHT), prevent the ER ligandbinding domain from adopting the conformation required for interaction with AF2-dependent coactivators (33), but do not interfere with DNA binding. "Pure" antiestrogens such as ICI 182,780 and RU 58,668 are thought to alter cytoplasmic-nuclear shuttling of hER␣ and to increase receptor degradation (34 -36) and might be expected to impair the ability of ER-KRAB chimeras to repress transcription. To facilitate comparisons of the ability of the different ligands to induce repression, we set luciferase activity in the absence of transfected KERK equal to 100% for each ligand. Repression was not affected by the type of ligand used. Transcription was repressed by 75-89% in the presence of 17␤-estradiol, OHT, or ICI 182,780. Surprisingly, repression was most effective when ICI 182,780 was present, indicating that KERK⅐ICI 182,780 complexes are not rapidly degraded and translocate into the nucleus and bind to ERE-containing DNA. OHT and ICI 182,780 also elicited efficient repression as KERK ligands in the estrogen receptornegative HepG2 cell line (data not shown), indicating that repression was not due to the SERMs interfering with hERmediated transcription activation.
Effect of the Number of EREs and ERE Binding Affinity on Transcription
Repression-Virtually all studies employing KRAB repressors have utilized conditions favorable to repression in which the KRAB chimera binds to synthetic constructs containing multiple copies of a perfect DNA-binding site (7-12, 14, 37, 38) . Since KERK repressed expression from the ER-EVIT promoter (which contains a single consensus ERE and three additional non-consensus EREs) less effectively than it repressed promoters containing four consensus EREs (Fig. 4,  D-F) , it was of interest to establish the minimum number of consensus EREs required for repression. We therefore constructed SV40-based reporter genes containing one, two, and four EREs and examined the ability of transfected KERK to repress their transcription (Fig. 6A) . Repression was similar for the reporter genes containing two or four EREs and reached a plateau at 87%. Although repression from the reporter gene containing a single ERE was dose-dependent, the inability to reduce promoter activity below ϳ30% of basal activity, even at high levels of transfected KERK, was troubling (Fig. 6B) . We therefore set out to enhance the potential of KERK to repress transcription.
Through the use of a modified form of the bacteriophage p22 challenge phage selection system (39), our laboratory recently identified progesterone receptor DNA-binding domain muta- tions that changed the DNA binding specificity from the glucocorticoid response element/progesterone receptor element to the ERE and that resulted in enhanced binding to the consensus ERE and to the imperfect ERE in the pS2 gene (16) . One of the progesterone receptor DBD mutants we isolated, DBD5, exhibited Ͼ10-fold higher affinity than the wild-type ER DBD for the consensus and pS2 EREs. We reasoned that enhancing the ability of KERK to bind to the ERE might potentiate its transcription repression properties. Therefore, the corresponding three mutations (E203W, Q214A, and H216G) from the progesterone receptor DBD5 mutant were introduced into the DNA-binding domain of KERK, resulting in KERK-3M. We compared the ability of KERK-3M and KERK to repress transcription from the promoter containing a single ERE. KERK-3M was a more potent repressor than KERK. Almost 2-fold less transfected KERK-3M was required to reach a given level of repression, and the extent of repression by KERK-3M increased progressively at all of the amounts tested (Fig. 6B) .
KERK-3M, but Not KERK, Effectively Represses Transcription from a Promoter Containing the Imperfect pS2 ERE-
Although the above studies demonstrate that KERK and KERK-3M are able to repress transcription from a single consensus ERE, most estrogen-regulated genes contain imperfect EREs. To test repression from an ERE in a native gene, we elected to use a fragment from the estrogen-inducible pS2 gene that contains the single imperfect ERE (5Ј-AGGTCActgTG-GCCC-3Ј) responsible for the strong estrogen induction of pS2 gene expression. Although pS2 is a clinical and prognostic marker for hormone-responsive breast cancer (40) , the function of pS2 and its role in breast cancer development and progression remain poorly understood.
In vitro DNA binding and in vivo transactivation by wildtype ER and by the ER DBD are both substantially reduced when the non-consensus pS2 ERE is present rather than the consensus ERE (41) . Since binding of the ER to an imperfect ERE is difficult to study directly in intact cells, as a test of pS2 ERE-ER interaction, we tested ER-mediated transactivation from a single pS2 ERE. We inserted the three up-binding mutations used in the KERK-3M repressor (E203W, Q214A, and H216G) into the DBD of wild-type hER␣ (hER-3M) and assessed the ability of the resulting hER-3M to activate transcription from the pS2 ERE. Relative to wild-type hER, 10 or 50 ng of transfected hER-3M increased transactivation from the pS2 promoter by 2.5-and 1.9-fold, respectively (n ϭ 6; data not shown). This supports the view that these mutations enhance FIG. 4 . KERK effectively represses transcription on several estrogen-responsive promoters in HepG2 and CHO cells in the presence and absence of hER. Repression was assessed in the presence of 10 nM moxestrol in the presence and absence of the indicated amounts of cotransfected hER␣ or hER␤ expression plasmids using reporter plasmids (ERE) 4 -pGL3-TK, (ERE) 4 -pGL3-SV40PE, and (ERE) 4 -pGL3-EF-1␣ in HepG2 cells (A-C, respectively) and plasmids (ERE) 4 -pGL3-TK, (ERE) 4 -pGL3-SV40PE, and pGL3-EREVIT in CHO cells (D-F, respectively) . The transfections and luciferase assays were carried out as described under "Experimental Procedures." The data represent the mean Ϯ S.E. of at least three independent transfections normalized to the activity of the indicated reporter plasmid alone, which was set equal to 100%.
FIG. 5. Antiestrogens induce repression by KERK in MCF-7
human breast cancer cells. Repression was assessed on the (ERE) 4 -pGL3-SV40PE reporter plasmid in the presence of 17␤-estradiol (10 nM), OHT (10 nM), or ICI 182,780 (10 nM). Transfections and luciferase assays were carried out as described under "Experimental Procedures." Since the different effects of agonists and antagonists on the growth of MCF-7 cells influenced the activity of the internal standard, to facilitate comparisons, the data obtained for each individual treatment group were normalized against the luciferase activity of the reporter plasmid alone in the absence of transfected chimera, which was set at 100%. The average luciferase units for each treatment were as follows: no ligand, 170,000; 17␤-estradiol, 39,000; ICI 182,780, 60,000; and OHT, 198,000. The data represent the mean Ϯ S.E. of at least three independent transfections.
in vivo binding of the ER to the pS2 ERE.
To evaluate whether KERK and KERK-3M could repress transcription from an imperfect ERE in a native promoter context, we constructed a pS2-based reporter gene using the 345-nucleotide fragment from the pS2 promoter that contains the pS2 ERE (15) . KERK only weakly repressed moxestrol/ hER-induced transcription of the pS2-based reporter and was unable to repress basal transcription of the reporter (Fig. 7A) . In striking contrast, the KERK-3M chimera effectively repressed all of the moxestrol/hER-induced transcription and elicited a strong dose-dependent repression of basal promoter activity (Fig. 7B) . These data indicate that use of a genetically selected set of up-binding mutations strongly potentiates the ability of ER-KRAB chimeras to repress transcription from a naturally occurring imperfect ERE. DISCUSSION 
ER-KRAB Chimeras Containing ER Activation Domains Re-
press Transcription-In a study of repression of the human immunodeficiency virus type 1 long terminal repeat, dominantnegative Tat mutants linked to KRAB were far more effective repressors than Tat-KRAB chimeras retaining an active Tat transactivation domain (42) . In a similar way, ER activation domains could interfere with KRAB repressor activity since the putative KRAB corepressor TIF1␣ acts as a coactivator on interaction with the AF2 domain of ligand-occupied ER (23) . Deleting or mutating one or both ER transactivation domains did not enhance repression of transcription, indicating that the KRAB domain is dominant over the ER transactivation domains and can overcome the activity of any ER coactivators still able to bind the ER-KRAB chimeras.
KERK Represses Transcription when Wild-type ER Is Present-If the ER-KRAB chimeras and wild-type ER have similar affinities for the ERE, it seemed plausible that wild-type ER could compete effectively for binding to the EREs in our reporter genes and might block the ability of the KRAB chimeras to repress transcription. Consistent with our finding that the KRAB domain is dominant over the AF1 and AF2 domains, we found that KERK effectively represses transcription in the presence of either hER␣ or hER␤ in several cell and promoter contexts (Fig. 4) . FIG. 6 . Repression from a single consensus ERE is increased when ERE binding by the chimera is enhanced. Transfections and luciferase assays were carried out as described under "Experimental Procedures." In all cases, the data obtained were normalized against the luciferase activity of the indicated reporter plasmid alone, which was set at 100%. A, transcription repression by the KERK chimera was assessed in HepG2 cells on pGL3-SV40PE reporter plasmids containing the indicated number of EREs (REs). B, repression by KERK and by a mutant KERK possessing increased DNA binding (KERK-3M) was assessed in HepG2 cells on the (ERE) 1 -pGL3-SV40PE plasmid. Note that the data for the KERK chimera are also shown in A. Because of its enhanced effectiveness as a repressor, 16 ng was the highest level of KERK-3M tested. The data represent the mean Ϯ S.E. of at least three independent transfections. Not only can KERK repress transcription in the presence of ER, it also represses transcription of the powerful (ERE) 4 -pGL3-EF-1␣ reporter, whose expression is not up-regulated by the ER. In the progression of breast cancers to an estrogenindependent phenotype in which antiestrogens no longer limit their growth, it has been suggested that genes that were initially estrogen-regulated become constitutively active (43) (44) (45) . The (ERE) 4 -pGL3-EF-1␣ construct serves as a prototype for this class of genes. KERK effectively suppresses the high level of basal transcription from this promoter (Fig. 4C ).
An ER Ligand Is Required for Repression-The role of ligand in ERE binding by the ER has been controversial (reviewed in Ref. 46) . Although most studies support the view that liganded ER binds with higher affinity to the ERE than unliganded ER, variable levels of ERE binding by unliganded ER have been reported using promoter interference assays (46 -48) . We observed a minimum level of repression with unliganded KERK (Fig. 1A) . The presence of ER ligands that are either agonists or antagonists strongly potentiated repression by KERK. Since ER-KRAB chimeras in which the KRAB domain was linked to either the N or C terminus had equal potency (Fig. 2B) , the presence of the large KRAB repressor domain linked to the C terminus of the ER does not appear to limit the access of ligand to the binding pocket.
The mechanisms by which pure antiestrogens such as ICI 182,780 interfere with ER-mediated transcription have been the subject of considerable interest (49) . The ER occupied by pure antiestrogens is thought to be largely localized in the cytoplasm (34, 35, 50) , where it is rapidly destroyed (34, 35) , depleting cellular ER. Although ICI 182,780-occupied receptor binds DNA in vitro with slowed kinetics (51), in vivo, at least part of the receptor population retains the ability to bind to the ERE (48) . Since KERK displayed a similar dose-dependent repression curve when liganded by 17␤-estradiol, OHT, or ICI 182,780, our data suggest that even ICI 182,780 induces KERK binding to the ERE. The putative KRAB corepressor TIF1␣ may potentiate nuclear localization of ICI 182,780-occupied KERK. In a study using an ER mutant missing the nuclear localization signal, the ER coactivator TIF1␣ allowed liganddependent nuclear localization (23) .
The Histone Deacetylase Inhibitor Trichostatin A Does Not Interfere with Repression by the KRAB Domain-One possible explanation for the ability of the KRAB domain to repress transcription is that it recruits a corepressor complex containing histone deacetylase activity. Since the histone deacetylase inhibitor trichostatin A (27, 28) had not previously been used in conjunction with the KRAB repressor, we examined its ability to interfere with repression by the KRAB domain. Trichostatin A did not affect repression by two KRAB chimeras on several promoters. Under these conditions, which employ transient transfections, KRAB repression uses a pathway independent of histone deacetylation. One possible explanation for these data is that the maintenance of a repressed chromatin state by the KRAB domain involves the heterochromatin-enriched factors HP1a, MOD1, and MOD2, which reportedly interact with KRAB corepressors TIF1␣ and TIF1␤ (13, 52, 53) . These factors may prevent histone acetylases involved in the relief of repression from gaining access to their substrates.
Binding to a Single ERE Is Sufficient for KRAB RepressionOur studies show that a GAL4-KRAB chimera and an ER-KRAB chimera each exhibit DNA sequence-specific repression and that changing the DNA binding specificity of an ER-KRAB chimera abolishes KRAB repression in ERE-containing genes (Fig. 1) . This corroborates earlier findings that tethering the KRAB domain to DNA is required for repression (7-12, 14, 37, 38) and demonstrates that our ER-KRAB chimeras are targeted to EREs.
We find that a single ERE is sufficient for KRAB-mediated repression. After completion of our work, a meeting report described effective repression by a different type of steroid receptor-based KRAB repressor (54) . After completion of this paper, successful repression of ERE-containing promoters by ER-NCoR fusions was reported (55) . Our data indicate that different rules apply for transcription activation and repression. Although cell type and promoter context play a critical role in the induction of transcription by the ER, the level of KRAB repressor occupancy of the ERE appears to be the overriding factor in repression. In addition, our data demonstrate that it is the presence of the ERE, rather than the capacity for estrogen induction, that determines the potential for repression of a gene by an ER-KRAB chimera. Consistent with these conclusions is our finding that the extent of repression was similar from the thymidine kinase, SV40, and elongation factor 1␣ promoters containing the same number of EREs, whereas induction by the ER varied from 15-fold to 0 on these promoters.
Interestingly, although synergism between ER bound at different EREs can mask diminished binding (56) when the ER is activating transcription, this is not true for KRAB-mediated repression. Two EREs were clearly more effective in enabling repression by KERK than a single ERE, but there was no further increase in repression in going from two to four EREs (Fig. 6A ). This contrasts with hER-mediated transcription activation in the same cell line, where strong synergistic effects were seen in comparisons of activity on reporter genes containing one, two, and four EREs (18, 56) . Additional support for the idea that tight binding to a response element is important for KRAB repression comes from studies with the promoter fragment containing the pS2 ERE. The ER binds to the pS2 ERE with a lower affinity than to the consensus ERE (15, 41) . Despite this diminished binding, hER achieved a 3-fold transcription activation on the pS2 ERE. In striking contrast, KERK was unable to suppress basal promoter activity when bound to the same pS2 ERE. The ability of KERK to partially suppress ER-mediated induction of the reporter containing the pS2 ERE may stem from the ability of KERK to act as a dominant-negative mutant interfering with the binding of wild-type ER, without exerting active repression. In contrast, KERK-3M achieved effective dose-dependent transcription repression of the pS2 ERE. This suggests that high affinity binding to the imperfect ERE, resulting in the continued presence of the ER-KRAB chimera on the promoter, is critical for repression.
Combining Genetic Selection with ER-KRAB Chimeras Provides a Novel Approach to Targeting Genes for Repression-
Most studies of gene targeting use multiple rounds of phage display to select mutant DNA-binding domains with affinity for a DNA target (57, 58) . The resulting proteins do not provide for ligand-regulated activation or repression. Our surprising finding that binding of ER-KRAB chimeras to the ERE can be modulated either by estrogens or by the widely used SERMs OHT and ICI 182,780 makes ligand-dependent modulation of gene activity feasible using these chimeras. The ability to use the pure antiestrogen ICI 182,780 to activate ER-KRAB repressors enhances their long-term potential for use as gene repressors in breast cancer cells and in other systems in which use of ER agonists would be inappropriate.
We recently described a genetic selection using a modified form of the bacteriophage p22 challenge phage selection system, which requires only a single selection cycle (16) . To repress transcription from the imperfect pS2 ERE, it proved essential to modify the KRAB repressor using information from our recent genetic selection for DBDs with altered and enhanced ERE binding (16) . To produce the KERK-3M repressor, we combined information from our genetic selections performed using steroid receptor DNA-binding domains with the KERK chimera, whose ability to repress transcription can easily be modulated using ER ligands. The KERK-3M repressor provides a model for a novel class of gene-targeting protein that combines the ease of use of a ligand-regulated steroid receptor with specificity and affinity gained through large-scale genetic selection. The unique characteristics of these hER-KRAB chimeras make them powerful new tools for the functional analysis of ER-regulated genes.
